In 2017, cancer drugs once again dominated the news, with many of these medications making headlines for being the first of their kind to gain approval. Beyond cancer, drugs for inflammatory diseases also received attention, for both their successes and their failures.
Fonte: VOLUME 23 | NUMBER 12 | DECEMBER 2017 NATURE MEDICINE
Para acessar a publicação na íntegra clique aqui
Click here to original publication.